![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/spacer.gif)
pyruvate kinase inhibitor TLN-232 A synthetic cyclic heptapeptide with potential antineoplastic activity. Pyruvate kinase (PK) inhibitor TLN-232 targets pyruvate kinase M2 (M2PK), which may disrupt tumor cell anaerobic glycolysis. M2PK is a dimeric isoform of PK and the predominant PK isoform found in tumor cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/spacer.gif)
Code names: | ![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/spacer.gif) | CAP-232 TLN-232 | | ![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/spacer.gif)
Previous: | pyrazofurin, pyrazoloacridine, pyridoxine hydrochloride, pyrimethamine, pyroxamide | Next: | QS21, Quadramet, quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, quarfloxacin, quinacrine dihydrochloride |
|
![](https://webarchive.library.unt.edu/eot2008/20090116012518im_/http://www.cancer.gov/images/spacer.gif) |